sb 203580 has been researched along with rmi 12330a in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (rmi 12330a) | Trials (rmi 12330a) | Recent Studies (post-2010) (rmi 12330a) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 141 | 0 | 24 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kageyama, K; Suda, T | 1 |
1 other study(ies) available for sb 203580 and rmi 12330a
Article | Year |
---|---|
Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5'-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells.
Topics: Animals; Aorta; Cells, Cultured; Corticotropin-Releasing Hormone; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Flavonoids; Imidazoles; Imines; Indoles; Interleukin-6; Isoquinolines; Maleimides; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Protein Kinase C; Pyridines; Rats; Sulfonamides; Urocortins | 2003 |